跳至主要内容
临床试验/CTRI/2023/08/056088
CTRI/2023/08/056088尚未招募2 期

Effect of Rasnadarvadi Kashaya Orally along with Trivrit Taila Anuvasana Basti & Mefanamic acid in Kashtartava with special reference to Primary Dysmenorrhoea - Nil

Bananras Hindu University0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age group 18 -30 years.
  • Patients complaining of painful menstruation for at least 2 consecutive cycles.
  • Patients having regular menstrual cycle.
  • Patients who are ready for necessary investigations and agreed to come for follow up regularly.
  • Patients who are ready for the trial and ready to sign the informed consent.

排除标准

  • Patient of age less than 18 and above the age of 30 years.
  • Patients with any history of allergy or allergy from trial drugs.
  • Pregnant women, women with chronic ailments (systemic diseases like TB, DM, jaundice, bronchial asthma, cardiovascular diseases, renal problems), piles, fistula, fissures or having any history of psychological disorders
  • Patient having congenital anomalies leading to dysmenorrhoea.
  • Patient having pelvic inflammatory disease, pelvic neoplasm.
  • Patient taking any hormonal therapy and IUCD

研究者

发起方
Bananras Hindu University

相似试验